Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences. 

He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine. He then undertook a research degree from the University of Birmingham, UK which led to the award of an MD. He pioneered the development of a continuous blood gas monitoring system which reached clinical application. 

He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014–2016. He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World Federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy. 

He led the NHMRC funded multi-center international ADRENAL trial which is the largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state," sepsis and vitamin D in critical illness. 

In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute's Covid-19 research program in India and played a key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock. 

He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow. 

Bijini is Data Manager at the George Institute for Global Health. She has completed Masters in Computer Applications from Kakatiya University, Warangal, India. She has more than 9 years of experience with expertise in developing databases for surveys, community and hospital based observational studies and randomised clinical trials using different electronic data capture platforms. Her work at George includes database setup and deployment, database maintenance including mid-study updates, data reviews, data cleaning, database lock and archival. 

Professor Neal is a UK-trained physician who has 25 years’ experience in clinical, epidemiological, and public health research with a focus on heart disease, stroke and diabetes. 

He has a longstanding interest in high blood pressure and diabetes and the potential for both clinical interventions and changes in the food supply to deliver health gains.  His work has been characterised by its focus on collaboration, quantitation, translation and impact.  

He holds professorial appointments at UNSW Sydney, Imperial College London, and an honorary appointment at the University of Sydney.  He has published some 450 scientific papers and since 2016 has been identified by Thomson Reuters as one of ‘The World’s Most Influential Scientific Minds’ - an acknowledgement bestowed on just a few thousand researchers across all disciplines worldwide.  

He has deep expertise in the conduct of large-scale clinical trials addressing cardiovascular disease but has also done a significant body of work addressing food policy issues related to sugars, fats, portion size and food labelling.

Dr Candice Delcourt is a clinician researcher. She holds an NHMRC Investigator Grant, Synergy Grant and MRFF funding. She is a Senior Research Fellow and Head of the Neurology Program at The George Institute.

She is a Clinical Associate Professor at Macquarie University and a Conjoint Senior Lecture at The University of New South Wales. She is a practicing neurologist in Sydney and in rural outreach locations. Her research interests are stroke, health systems, clinical trials and epidemiology.

Professor Clara Chow is a cardiologist committed to reducing the burden of cardiovascular disease through prevention and innovative approaches to achieve this. She is Program Director Community Based Cardiac Services, Westmead Hospital and Professor of Medicine, Western Clinical School, Sydney Medical School, University of Sydney.

She has a PhD in Medicine from the University of Sydney and completed a postdoc in Cardiovascular epidemiology and clinical trials at McMaster University, Canada. Clara holds a Career Development Fellowship of the NHMRC co-funded by the National Heart Foundation. She has over 100 publications, focused on clinical and community approaches to cardiovascular prevention and including papers in leading international journals. She led the initial TEXT ME trial that showed text messaging programs were effective in lowering cholesterol, blood pressure and weight in patients with coronary heart disease. 

Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia.  

Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Investigator Fellow of the National Health and Medical Research Council (NHMRC) of Australia.  He is a past President of the Asia Pacific Stroke Organisation and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group.  He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.

Dr. Devarsetty Praveen is a public health expert with deep knowledge of epidemiological research and a strong focus on using system-based innovations to tackle inequities in chronic disease care. He serves as the Director of the NIHR-funded Global Health Research Center for NCDs and Environmental Changes, as well as the Director of the Primary Health Care Research Consortium Secretariat. In these roles, he leads research efforts that are policy-relevant and aim to strengthen high-quality primary health care systems globally.

Dr. Praveen has extensive experience in designing and implementing large-scale primary care research projects, particularly using digital health strategies (e/m-health) in countries such as India, Indonesia, Bangladesh, Myanmar, and Thailand. He applies mixed-methods research and implementation science to integrate proven evidence into routine practice, improving access to quality health care.

He is the elected Co-Chair of the Hypertension Research Program within the Global Alliance for Chronic Diseases, a network of major research funding agencies dedicated to addressing chronic non-communicable diseases. Dr. Praveen holds a PhD in Medicine from the School of Public Health, University of Sydney.

Professor Peiris plays a lead role in developing and implementing the institute’s research strategy. He is a Professor in the Faculty of Medicine, UNSW Sydney, and is a locum GP with Miwatj Health visiting Galiwin’ku, Elcho Island.

David is passionate about strengthening primary health care worldwide. He is focussed on overcoming the challenges of delivering affordable, high-quality health services and programs to communities across the globe. His research is underpinned by health systems science, a dynamic and emerging discipline that includes health services research, health policy and systems research, and implementation science.

David has published extensively and leads several grants testing innovative strategies to improve access to high-quality primary health care. He is a former Australian Harkness Fellow in Healthcare Policy, based at the Harvard School of Public Health, and was the elected co-chair of the Global Alliance for Chronic Diseases Committee for Hypertension Control from 2012 to 2015. He sits on several government, non-government and research advisory committees. He is a Lancet commissioner focussed on evidence-based implementation in global health and pandemic preparedness.

Dijlah is the Impact and Engagement Support Officer for the global Impact and Engagement Team. She works actively across multiple programs and projects, supports events and the development of impact and engagement materials.

Dorrilyn Rajbhandari is a Senior Project Manager at the George Institute for Global Health. She is chair of the Project Manager Interest Group, and a member of the ANZICS Clinical Trial Group. As a Senior Project Manager, with many years of experience as a nurse clinician in intensive care research, she has vast experience in clinical trial management, operationalisation of protocols, including protocol development and design, CRF design, website and data management, multiple sub-studies, final analysis and resulting publications. She is a resource and mentor for colleagues.

Dorrilyn has successfully coordinated and managed many multi-centre, worldwide clinical trials in intensive care. She has successfully completed, within expected timelines, the CHEST study (7000 patients), ADRENAL study, a 3,800 patient study from 70 sites worldwide, including the ADRENAL-GEPS Sub-Study, with the largest severe sepsis cohort in precision medicine. The process provided experience in drug manufacture, regulatory requirements and regulatory approvals in multiple countries including importation and exportation processes and requirements, sample collections and transfers from around the world. Dorrilyn is currently project managing a number of studies; BLING III multicentre clinical outcome study, a 7000 patient study from 100 sites around the world. FluDReSS, a 300 patient study from 10 sites. HOPE, hydroxycholoquine prophylaxis in health care workers in India. 

Dorrilyn Rajbhandari has the expertise to implement, manage and complete efficiently within timelines, large multi-centre clinical trials with results published in high quality journals.

Elizabeth Dunford is a Project Consultant for The George Institute for Global Health’s Food Policy Division, Adjunct Senior Lecturer at the University of New South Wales and an Adjunct Assistant Professor at the University of North Carolina.

She is known internationally for her work in monitoring the global food supply and in the development of novel technologies to support this work in both developed and developing countries. She led the development of the Australian and US FoodSwitch food composition databases which are used to monitor changes in the nutritional composition of the food supply. The Australian database she developed in her PhD was used to create the FoodSwitch smartphone application; an innovative tool that helps consumers select healthier food choices. FoodSwitch has been downloaded >1,000,000 times and has been launched in multiple countries.

Elizabeth has an undergraduate degree in Human Nutrition, a Masters degree in Public Health, and a PhD in Public Health from The University of Sydney. In the 10 years following the completion of her postgraduate qualification in Public Health, Elizabeth has published 100+ peer-reviewed journal articles and has authored multiple commissioned policy documents for the World Health Organization, Access to Nutrition Initiative, World Bank and Unicef. 

Frances Bass works part-time at The George Institute for Global Health as Program Manager in the Critical Care Program. She also works at Royal North Shore Hospital as an Intensive Care Clinical Research Manager.

Frances is a Registered Nurse having completed a Bachelor of Nursing, Graduate Certificate in Critical Care, and Masters of Science (Research). She has extensive experience in the management of critical care clinical trials operations including investigator-initiated, collaborative group and commercially sponsored trials. 

Frances sits on a number of scientific management committees. She is Secretary for the Australian College of Critical Care Nurses (ACCCN) NSW/ACT Branch Management Committee and a member on the ACCCN Research Advisory Committee. She is Deputy Chair of the Northern Sydney Local Health District, Human Research Ethics Committee.